SecBot SecBot
144 ·Filed Nov 4, 2026

GILD

GILEAD SCIENCES, INC.
NEUTRAL
Impact 3/10
Horizonweeks Processed12d 5h ago SEC0001950047-26-010699
Form 144: notice of proposed sale of securities
Actionable Insight • Neutral

The sale is part of a pre-arranged 10b5-1 plan and is modest relative to market cap. Monitor upcoming quarterly filings for any change in insider selling patterns or option exercise volume.

DirectionNeutral
Confidencehigh
Horizonweeks

How the stock moved after the report

NEUTRAL VIEWSTOCK ABOVE ENTRY AT T+5
Entry
$167.57
T+0 close · Nov 4, 2026 · via day close
Latest settled
+0.23%
T+5 · $167.95 · next T+20 in 17d
Vs SPY
−3.06%
α at T+5
Latest observation
+1.03%
T+6 · FF3 residual α
  1. T+0 · Nov 5 $167.57entry
  2. T+1 · 11d ago −0.41%α −0.72% · $166.89
  3. T+5 · 5d ago +0.23%α −3.06% · $167.95
  4. T+7 · todayOpen
  5. T+20 · in 17d Pending
  6. T+60 · in 3mo Pending
Loading chart...

How similar events traded

How similar events traded

See how far stocks moved after events like this one.

Subscribe for Full Access

Executive Summary

CEO Daniel O'Day filed a Form 144 notice to sell 112,429 shares of Gilead Sciences common stock, valued at approximately $18.8 million, to be acquired through stock option exercises over the next three months. The filing also discloses prior 10b5-1 plan sales totaling about $9.8 million in the preceding weeks. While the sale is large in absolute terms, it represents a small fraction of the company's $211B market cap and appears to be part of a pre-arranged trading plan.

Key Facts

  • CEO Daniel O'Day filed Form 144 to sell 112,429 shares of common stock
  • Estimated aggregate value of proposed sale: $18,828,484.63
  • Shares to be acquired via exercise of stock options over the next three months
  • Prior 10b5-1 plan sales disclosed: 15,000 shares on 11/02/2026 ($2.55M), 15,881 shares on 10/30/2026 ($2.78M), 15,000 shares on 10/01/2026 ($2.22M), 15,000 shares on 09/01/2026 ($2.23M)
  • Total prior 10b5-1 sales: ~$9.78M
  • Market cap: $211.3B; proposed sale represents ~0.009% of market cap
  • Filing date: 2026-11-04; proposed sale date: same day

Financial Impact

CEO proposes to sell ~$18.8M in stock, with ~$9.8M already sold under 10b5-1 plan in prior months; total insider selling ~$28.6M over ~2 months

dilution

Risk Factors

  • CEO selling a large absolute dollar amount could signal personal diversification or reduced conviction, though 10b5-1 plans mitigate timing concerns
  • Continued insider selling may weigh on sentiment if it accelerates

Market Snapshot

Exchange
Nasdaq
Sector
Biological Products, (No Diagnostic Substances)
Analyst Consensus
83% bullish (36 analysts)

Investment Themes

Documents Analyzed

This report is based on 3 SEC documents filed with EDGAR.

DocumentAccession Number
144 Filing (Primary)0001950047-26-010699
Document: 0001950047-26-010699-index.html0001950047-26-010699
Document: 0001950047-26-010699.txt0001950047-26-010699

Track record

30 reports on GILD

Performance horizon

5 of 6 bullish or bearish reports moved the stock their way by T+60. Best: +22.38% at T+60 after the Aug 13, 2026 report. 5 of 8 went positive at some point.

Filters
  1. Nov 16, 2026today 144 Neutral 2/10 Entry $167.58 Now $167.58 +0.00% settles Feb 16
  2. Nov 16, 2026today Insider Cluster Neutral 2/10 Entry $167.71 Now $167.58 −0.08% settles Feb 12
  3. Nov 13, 20264d ago Court Ruling Bullish 4/10 Entry $170.99 Now $167.58 −1.99% settles Feb 12
  4. Nov 12, 20264d ago 144 Neutral 2/10 Entry $168.08 Now $167.58 −0.30% settles Feb 11
  5. Nov 9, 20267d ago Insider Cluster Neutral 2/10 Entry $170.87 Now $167.58 −1.93% settles Feb 8
  6. Nov 6, 202610d ago 144 Neutral 2/10 Entry $169.32 Now $167.58 −1.03% settles Feb 5
  7. Nov 4, 202612d ago 144 Neutral 3/10 Viewing Entry $167.57 Now $167.58 +0.01% settles Feb 3
  8. Oct 30, 202617d ago 144 Neutral 3/10 Entry $170.33 Now $167.58 −1.61% settles Jan 29
  9. Oct 29, 202618d ago 8-K Bullish 6/10 Entry $170.68 Now $167.58 −1.82% settles Jan 28
  10. Oct 22, 202625d ago Institutional Cluster Bearish 4/10 Entry $156.04 Now $167.58 −7.40% settles Jan 21
Showing 10 of 30

US Market Status

Market Closed · Opens Wed (11h 48m)

Subscribe to SecBot

Get Real-Time SEC Filing Intelligence

Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.

Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers
Report published Nov 4, 2026